Is redo percutaneous mitral balloon valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis?
Asad Z. Pathan, MDa,
Nasser A. Mahdi, MDa,
Miltiadis N. Leon, MDa,
Julio Lopez-Cuellar, MDa,
Hector Simosa, MDa,
Peter C. Block, MD, FACCa,
Lari Harrell, BSa and
Igor F. Palacios, MD, FACCa
a Cardiac Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

View larger version (24K):
[in a new window]
|
Figure 1 Survival and event-free survival of patients undergoing redo percutaneous mitral balloon valvuloplasty. Numbers in parentheses represent number of patients alive and uncensored (top curve) and alive and free of combined events uncensored (bottom curve) at the end of each time interval.
|
|

View larger version (23K):
[in a new window]
|
Figure 2 Comparison of long-term survival (A) and event-free survival (B) of patients undergoing redo percutaneous mitral balloon valvuloplasty without (top curves) and with (lower curves) associated comorbid diseases. Numbers in parentheses or brackets represent number of patients alive and uncensored (A) and alive and free of combined events uncensored (B) at the end of each time interval.
|
|
|